Back to Capital Research Global Investors Capital Research Global Investors

VRTXVRTX
23 quarters

Position history for Capital Research Global InvestorsCapital Research Global Investors's holdings in VERTEX PHARMACEUTICALS INC

Capital Research Global Investors holds 19.5M shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $9.7B as of 2026-Q2. The position was decreased (-7.7% shares). VRTX represents 1.4% of Capital Research Global Investors's portfolio.

Current Value

$9.7B

Current Shares

19.5M

Total Value Change

+$9.3B

Total Shares Change

+17.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
19.5M
-7.7%
$9.7B1.4%$496.73
0
2026-Q1
Increased
21.1M
+22.0%
$9.4B1.5%$474.27
60
2025-Q4
Increased
17.3M
+4.6%
$7.9B1.4%$453.74
53
2025-Q3
Increased
16.6M
+2.8%
$6.5B1.2%$395.31
52
2025-Q2
Increased
16.1M
+10.8%
$7.2B1.4%$441.30
56
2025-Q1
Increased
14.5M
+39.4%
$7B1.5%$492.69
66
2024-Q4
Increased
10.4M
+15.8%
$4.2B0.9%$399.35
52
2024-Q3
Increased
9M
+5.4%
$4.2B0.9%$462.88
47
2024-Q2
Increased
8.5M
+48.7%
$4B0.9%$468.72
62
2024-Q1
Increased
5.7M
+61.0%
$2.4B0.5%$418.01
65
2023-Q4
Increased
3.6M
+5.8%
$1.5B0.4%$406.89
40
2023-Q3
Increased
3.4M
+10.2%
$1.2B0.3%$347.74
42
2023-Q2
Increased
3.1M
+278.0%
$1.1B0.3%$348.18
62
2023-Q1
New
809,895
-
$255.2M0.1%$312.16
43
2020-Q4
Exited
0
-100.0%
$00.0%$232.68
0
2020-Q3
Decreased
1.3M
0.0%
$340.3M0.1%$270.31
0
2020-Q2
Decreased
1.3M
0.0%
$363.1M0.1%$285.18
0
2020-Q1
Increased
1.3M
0.0%
$297.6M0.1%$231.92
37
2019-Q4
Increased
1.3M
+0.0%
$273.8M0.1%$218.97
31
2019-Q3
Increased
1.3M
0.0%
$211.8M0.1%$166.74
30
2019-Q2
Increased
1.3M
+0.0%
$229.3M0.1%$183.38
31
2019-Q1
Decreased
1.3M
-39.5%
$229.9M0.1%$183.95
0
2018-Q4
New
2.1M
-
$342.2M0.1%$161.42
51

Other major holders of VRTX: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used